Main Sequence Research
Investment Thesis
Main Sequence is a deep tech venture firm built around a simple but demanding thesis: the hardest problems are also the biggest markets, and the most durable companies often come from scientific discovery rather than generic software iteration. The firm says it backs "unreasonable inventors" and invests in companies it creates and invests in, which is a useful clue to its operating style. Main Sequence was founded by CSIRO in 2017 to bridge the commercialization gap for research in Australia, and its website repeatedly emphasizes founders connected to publicly funded research, spinouts, and technically difficult industries.
The firm’s thesis is not just that deep tech can work, but that it requires a different kind of investor behavior. Main Sequence positions itself as hands-on and service-oriented, with a support platform for founders alongside capital. That is consistent with the tone of its blog posts and challenges pages, which frame the firm around major world problems rather than narrow verticals. The challenge areas are broad but coherent: space, decarbonization, next-generation computing, food systems, healthcare, and industrial productivity. In other words, Main Sequence is looking for technical companies with enough product and scientific depth to justify long build cycles and complex commercialization paths.
Stage Focus
Main Sequence is explicitly early, but not only seed. The website says it invests from seed to Series B, and its Atmosphere platform extends even earlier with first-check support for Australian deep tech startups. The firm’s current posture appears to be a blend of early-stage conviction and follow-on support for companies that can scale. The main fund relationship starts as early as possible, while Atmosphere is designed to add first capital and tailored mentorship for pre-seed and seed companies.
In practice, that means Main Sequence is most comfortable in the part of the market where technical risk is high, customer discovery is still active, and the investor may need to help shape the company as much as finance it. The firm does not read like a generalist growth investor. It reads like a technical early-stage partner that can support founders through long research-to-market transitions.
Check Size
The firm does not publish a single universal check size for every fund and strategy, so this profile uses a conservative range anchored by the public Atmosphere materials. Main Sequence says Atmosphere invests up to $500K in Australian companies, and each investment is led by a member of the investment team. That suggests an early check range that can begin in the low hundreds of thousands and cap around the half-million mark for the earliest platform checks.
For core-fund activity, the effective check size may be larger in follow-on rounds, but I would rather be conservative than invent a number the site does not clearly state. The key signal is that Main Sequence is willing to come in early and continue backing companies as they move toward larger rounds.
Lead Tendency
Main Sequence appears to lead often, especially when it has high conviction. The clearest recent evidence is ElectraLith, where the firm said it was excited to lead an oversubscribed A$27.5M Series A round. It also said it led Terria’s seed round, and its portfolio and blog language repeatedly imply active ownership of the round-building process rather than passive following.
That said, the firm is not a rigid solo-lead only investor. Its co-investor language and board participation suggest it is comfortable partnering with other firms when the round structure or technical domain benefits from a broader syndicate. The cleanest summary is that Main Sequence leads when it can, but is willing to collaborate.
Recent Activity
Recent public activity shows a firm that is actively deploying across its challenge areas and continuing to surface new deep tech opportunities. In 2025 and 2026 it publicly backed Terria, ElectraLith, Andromeda Robotics, Deteqt, and Aigentsphere. It also announced a $450M Fund III first close in 2023 and crossed $1B in funds under management, which remains an important scale marker for the platform.
The newer investments are especially informative because they show the breadth of the thesis in action: geospatial digital twins at Terria, critical minerals at ElectraLith, embodied AI and companion robotics at Andromeda, quantum sensing at Deteqt, and enterprise AI governance at Aigentsphere. This is not a one-theme firm; it is a deep tech platform that keeps returning to the same meta-pattern: difficult science, real-world deployment, and measurable operational value.
Portfolio Highlights
Main Sequence’s portfolio is broad, but a few names capture the style well:
- Q-CTRL, which fits the firm’s quantum and next-generation computing interest.
- Morse Micro, which reflects its hardware, connectivity, and infrastructure depth.
- Loam Bio, which maps to its climate and bioeconomy themes.
- Emesent, which sits squarely in robotics and autonomy.
- Advanced Navigation, which underscores robotics, aerospace, and sensing.
- SunDrive, which fits clean energy and hard-tech manufacturing.
- Terria, which shows comfort with infrastructure software and geospatial data.
- ElectraLith, which is a clean-energy and critical-minerals example.
- Andromeda Robotics, which demonstrates embodied AI and healthcare-adjacent robotics.
- Deteqt, which demonstrates quantum sensing and defensible hardware science.
The portfolio strongly supports the idea that Main Sequence likes companies where technical depth, long cycles, and real-world deployment matter more than growth-hacking.
Team
- Bill Bartee, Managing Partner
- Gabrielle Munzer, Partner
- Mike Zimmerman, Partner
- Elaine Stead, Principal
- Jun Qu, Investment Manager
- Grace Bird, Head of Atmosphere Pre-seed Fund
The team structure matters because the firm appears organized around thematic ownership. That supports the view that Main Sequence is not a generic committee shop; it is a specialist platform with investors aligned to challenge areas.
Decision Process
The decision process looks partnership-driven rather than solo-GP led. The site emphasizes an apprenticeship model, hands-on support, and direct work with founders on customer introductions, business model questions, and strategic guidance. That points to a collaborative internal process where conviction is formed through discussion, technical depth, and founder engagement rather than quick financial screening alone.
The firm also seems willing to spend time on pre-investment support, especially through Atmosphere and office-hour style interactions. That suggests a measured process that values comprehension of the science, the market, and the commercialization path.
Founder Preferences
Main Sequence clearly prefers technical founders, researchers, and spinout teams working on hard problems. It repeatedly emphasizes founders connected to publicly funded research and people who can translate lab-grade science into venture-scale companies. The firm is drawn to founders with deep technical credibility, patience, and the ability to operate through long product and market development cycles.
It also seems to favor founders who are willing to work closely with the firm on strategy, hiring, customer discovery, and commercialization. The implicit anti-thesis is a company that is not genuinely deep tech, lacks a defensible technical wedge, or does not have a credible path from research to deployment.
Geographic Focus
Main Sequence is Australia-first. Its headquarters are in Eveleigh, NSW, and its origin story is tightly linked to CSIRO and Australia’s research ecosystem. At the same time, its portfolio and recent activity show global ambition. The firm talks about building global companies, collaborates with a global co-investor base, and supports international scaling when the company merits it.
The practical summary is straightforward: Australia is the home base and sourcing advantage, but the market is global when the science and customer pain are big enough.